secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0001213900-24-105072
Event type: debt
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix obtains waiver of October payment to Veru; future payment percentage rises to 25%
--------------------------------------------------------------------------------

- Waives Oct 2024 cash receipt payment due Nov 20, 2024 until Onconetix receives at least $97,000 from Keystone equity line.
- In exchange, Onconetix increases Veru's share of net proceeds from future financings/strategic transactions to 25% (from 20%) through June 30, 2025.
- Onconetix states it lacks sufficient cash reserves to pay the October Cash Receipt Payments on time.
- Amendment executed November 26, 2024; extends forbearance terms under existing April 2024 note agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024105072/0001213900-24-105072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024105072/ea0223490-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-105072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer